NCI Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) supplement funding opportunities are available for current awardee small businesses. Supplement funding is awarded in addition to project funding to help portfolio companies move forward with commercialization. If you are interested in applying for supplement funding, please reach out to your project officer.
Administrative Supplement
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) (PA-20-272)
This administrative supplement funding opportunity is designed to meet increased costs that are within the scope of the approved award, but were unforeseen when the new or renewal application or grant progress report for non-competing continuation support was submitted.
Commercialization Readiness Pilot Program Technical Assistance
- Commercialization Readiness Pilot (CRP) Program Technical Assistance (PAR-20-129)
The Funding Opportunity Announcement (FOA) aims to facilitate the transition of previously funded SBIR and STTR Phase II and Phase IIB projects to the commercialization stage by providing additional support for technical assistance not typically supported through Phase II or Phase IIB grants or contracts. This may include preparation of documents for a submission to the Food and Drug Administration, development of an intellectual property strategy, and/or planning for a clinical trial. Although a significant amount of the work in a CRP award may be subcontracted to other organizations, the small business concern is expected to maintain oversight and management of the research and development throughout the award. Clinical trials not accepted under this FOA.